Table 3 Results of the diagnostic ability of EUS-FNA and ERCP in patients with pancreatic cancer

EUS-FNA

 Cytological diagnosis

91.9% (147/160)

  Positive

125

  Suspicious positive

22

  Negative

13

 Histological diagnosis

83.1% (133/160)

  Adenocarcinoma

120

  Suspicious adenocarcinoma

13

  No diagnosis (atypia/inadequate/benign)

27 (18/8/1)

 Overall

94.4% (151/160)

ERCP

 Sample collection methods

  Pancreatic juice cytology

25.0% (6/24)

  Pancreatic ductal brush cytology

34.8% (8/23)

  Fluoroscopic pancreatic duct biopsy

44.4% (4/9)

  Biliary juice cytology

46.7% (7/15)

  Bile duct brush cytology

18.2% (2/11)

  Fluoroscopic bile duct biopsy

41.7% (20/48)

Overall

45.5% (40/88)